Physician profile
Eric A Payne
NPI 1356306864
$1,220.75
in general payments reported to CMS, 2019-2025
15 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.27 · 2021: $219 · 2022: $297 · 2023: $355 · 2024: $83.10 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $269.39 | 2021-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $243.51 | 2021-2025 | |
| Allergan, INC. | $230.79 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.63 | 2022-2025 | |
| Renalytix Ai, INC. | $85.80 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Astrazeneca Pharmaceuticals LP | $37.55 | 2024 | Breztri |
| Pfizer INC. | $32.17 | 2020-2025 | |
| Lilly USA, LLC | $30.51 | 2021-2022 | |
| Glaxosmithkline, LLC. | $22.89 | 2021 | |
| Checkpoint Surgical, INC | $22.83 | 2025 | Checkpoint Stimulators |
| Eisai INC. | $20.62 | 2021 | |
| Horizon Therapeutics Plc | $17.40 | 2021 | |
| Qiagen, LLC | $16.44 | 2022 | |
| Novo Nordisk INC | $13.17 | 2020 | |
| Jazz Pharmaceuticals INC. | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.